Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 20 results for "olopatadine"

New and Generic Drug Approvals: Patanase

Drug Name(s) PATANASE FDA Application No. (NDA) 021861 Active Ingredient(s) OLOPATADINE HYDROCHLORIDE Company ALCON PHARMS LTD Original Approval or Tentative Approval Date April 15, 2008 Chemical Type 3New dosage form Review ... U.S. Food and Drug Administration, 1 month ago

1 images for "olopatadine"

Medagadget.com, 7 months ago

Patent Issued for Stable Fixed Dose Pharmaceutical Composition Comprising Mometasone and Olopatadine (USPTO 9370483)

By a News Reporter-Staff News Editor at Drug Week From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Dhuppad, Ulhas R. (Maharashtra, IN); Katkurwar, Ashok (Maharashtra, IN); Gupta, Yashwant (Maharashtra, IN); Ankam, ...
 Pharmacy Choice1 month ago

Structural and Physicochemical Studies of Olopatadine Hydrochloride Conformational Polymorphs

Crystal and molecular structures of 2 conformational polymorphs (forms I and II) of olopatadine hydrochloride, an antiallergic agent, are presented. Both crystal modifications crystallize in the monoclinic crystal system with 1 olopatadine ...
 Pharmacist.com1 month ago

Temporary Tattoo Industry Supply, Consumption and Analysis of Top Key Manufacturers/Player 2016

(Before It's News) Temporary Tattoo Industry Summery The Global and Chinese Temporary Tattoo Industry, 2011-2021 Market Research Report is a professional and in-depth study on the current state of the global Temporary Tattoo industry with a ...
 Before It's News2 weeks ago

Argentum Pharmaceuticals and KVK Tech Succeed in Starting Patent Cancellation Trial Against Alcon's PAZEO®

NEW YORK , Aug. 1, 2016 /PRNewswire/ --The U.S. Patent & Trademark Office (PTO) granted a petition for inter partes review (IPR) filed by Argentum Pharmaceuticals LLC and its manufacturing partner KVK Tech, against all challenged claims of the sole ...
 WorldNetDaily3 weeks ago Argentum And KVK Tech Succeed In Starting Patent Cancellation Trial Against Alcon's PAZEO  BioSpace3 weeks ago ARGENTUM PHARMACEUTICALS : and KVK Tech Succeed in Starting Patent Cancellation Trial Against Alcon's PAZEO┬«  4 Traders3 weeks ago
[x]  

Alcaftadine superior in reducing itching from grass, tree pollens

r eviewed by Take-home message: Alcaftadine ophthalmic solution 0.25% (Lastacaft, Allergan) displayed superior efficacy in a comparison with olopatadine hydrochloride ophthalmic solution 0.2% (Pataday, Alcon). At both 16 and 24 hours after dosing, ...
 Ophthalmology Times1 month ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less